✦ LIBER ✦

1245 Zoledronic acid and Taxotere (ZANTE) metronomic and sequential administration in patients with hormone refractory prostate cancer (HRPC) – final results of phase I study

✍ Scribed by M. Caraglia; A. Morabito; M. Marra; A.M. Bochicchio; M.C. Piccirillo; R. Franco; F. Perrone; A. Budillon; R.V. Iaffaioli; G. Facchini

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Docetaxel and zoledronic acid combinatio

✍ G. Facchini; M. Caraglia; A. Morabito; S.G. Bruni; G. Nasti; P. Maiolino; S. Str 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 38 KB

Weekly administration of docetaxel in co

✍ Carles, J; Font, A; Mellado, B; Domenech, M; Gallardo, E; González-Larriba, J L; 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 113 KB

211 POSTER Results of a phase II study o

✍ R. DeJager; L. Roman; N. Lopatkin; P. Karlov; H.B. Breitz; R. Earhart 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Early results of a multicenter phase 2 s

✍ U. Steiner; K. Miller; S. Machtens; B. Backhaus; M. Siegsmund 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 226 KB

4010 POSTER Satraplatin increases progre

✍ C. Sternberg; O. Sartor; D. Petrylak; J.A. Witjes; I. Bodrogi; P. Harper; J.P. D 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 67 KB

704 POSTER A phase I dose escalation and

✍ E. Raymond; F. Goldwasser; G. Bousquet; C. Le Tourneau; S. Faivre; H. de-Montser 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 64 KB